A Genetics Perspective on the Role of the (Neuro)Immune System in Schizophrenia

Overview

Journal Schizophr Res

Specialty Psychiatry

Date 2019 Mar 10

PMID 30850283

Citations 21

Authors

Rebecca Birnbaum

Daniel R Weinberger

Affiliations

Soon will be listed here.

Abstract

The immune system has long been hypothesized to play a role in schizophrenia pathogenesis based on data from diverse disciplines. Recent reports of the identification of schizophrenia-associated genetic variants and their initial biological characterization have renewed investigation of the role of the immune system in schizophrenia. In the current review, the plausibility of a role of the immune system in schizophrenia pathogenesis is examined, by revisiting epidemiology, neuroimaging, pharmacology, and developmental biology from a genetics perspective, as well as by synthesizing diverse findings from the emerging and dynamic schizophrenia genomics field. Genetic correlations between schizophrenia and immunological disorders are inconsistent and often contradictory, as are neuroimaging studies of microglia markers. Small therapeutic trials of anti-inflammatory agents targeting immune function have been consistently negative. Some gene expression analyses of post-mortem brains of patients with schizophrenia have reported an upregulation of genes of immune function though others report downregulation, and overall transcriptome profiling to date does not support an upregulation of immune pathways associated with schizophrenia genetic risk. The currently reviewed genetic data do not converge to reveal consistent evidence of the neuroimmune system in schizophrenia pathogenesis, and indeed, a substantive role for the neuroimmune system in schizophrenia has yet to be established.

Citing Articles

Depression and Anxiety in Patients with Psoriasis: A Comprehensive Analysis Combining Bibliometrics, Latent Dirichlet Allocation, and HJ-Biplot.

Siteneski A, Montes-Escobar K, de la Hoz-M J, Lapo-Talledo G, Gutierrez Moreno G, Carlin Chavez E Healthcare (Basel). 2025; 13(5).

PMID: 40077004 PMC: 11899133. DOI: 10.3390/healthcare13050441.

A neuro-immune axis of transcriptomic dysregulation within the subgenual anterior cingulate cortex in schizophrenia.

Smith R, Mihalik A, Akula N, Auluck P, Marenco S, Raznahan A bioRxiv. 2025; .

PMID: 39990369 PMC: 11844519. DOI: 10.1101/2025.02.14.638357.

Identification of Diagnostic Schizophrenia Biomarkers Based on the Assessment of Immune and Systemic Inflammation Parameters Using Machine Learning Modeling.

Malashenkova I, Krynskiy S, Ogurtsov D, Khailov N, Druzhinina P, Bernstein A Sovrem Tekhnologii Med. 2025; 15(6):5-12.

PMID: 39944368 PMC: 11811831. DOI: 10.17691/stm2023.15.6.01.

A cross-section study of the comparison of plasma inflammatory cytokines and short-chain fatty acid in patients with depression and schizophrenia.

Yu H, Li R, Liang X, Yang W, Guo L, Liu L BMC Psychiatry. 2024; 24(1):834.

PMID: 39567940 PMC: 11577661. DOI: 10.1186/s12888-024-06277-y.

Expression pattern of long non-coding RNAs in treatment-naïve and medicated schizophrenia patients.

Javidi Aghdam K, Baradaran B, Rahmani S, Manafzadeh F, Noor Azar S, Aghayan S Sci Rep. 2024; 14(1):27654.

PMID: 39532914 PMC: 11557838. DOI: 10.1038/s41598-024-78220-w.

References

Zhu Y, Wang L, Yin Y, Yang E . Systematic analysis of gene expression patterns associated with postmortem interval in human tissues. Sci Rep. 2017; 7(1):5435. PMC: 5511187. DOI: 10.1038/s41598-017-05882-0. View

Jaffe A, Tao R, Norris A, Kealhofer M, Nellore A, Shin J . qSVA framework for RNA quality correction in differential expression analysis. Proc Natl Acad Sci U S A. 2017; 114(27):7130-7135. PMC: 5502589. DOI: 10.1073/pnas.1617384114. View

Andreassen O, Harbo H, Wang Y, Thompson W, Schork A, Mattingsdal M . Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci. Mol Psychiatry. 2014; 20(2):207-14. PMC: 4356743. DOI: 10.1038/mp.2013.195. View

Kleinman J, Law A, Lipska B, Hyde T, Ellis J, Harrison P . Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains. Biol Psychiatry. 2010; 69(2):140-5. PMC: 4351748. DOI: 10.1016/j.biopsych.2010.10.032. View

Kumar J, Liddle E, Fernandes C, Palaniyappan L, Hall E, Robson S . Glutathione and glutamate in schizophrenia: a 7T MRS study. Mol Psychiatry. 2018; 25(4):873-882. PMC: 7156342. DOI: 10.1038/s41380-018-0104-7. View

Hafizi S, Silva T, Meyer J, Kiang M, Houle S, Remington G . Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study. Neuropsychopharmacology. 2018; 43(8):1700-1705. PMC: 6006145. DOI: 10.1038/s41386-018-0061-5. View

Sekar A, Bialas A, de Rivera H, Davis A, Hammond T, Kamitaki N . Author Correction: Schizophrenia risk from complex variation of complement component 4. Nature. 2021; 601(7892):E4-E5. DOI: 10.1038/s41586-021-04202-x. View

Di Biase M, Zalesky A, OKeefe G, Laskaris L, Baune B, Weickert C . PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia. Transl Psychiatry. 2017; 7(8):e1225. PMC: 5611755. DOI: 10.1038/tp.2017.193. View

Notter T, Meyer U . Microglia and schizophrenia: where next?. Mol Psychiatry. 2017; 22(6):788-789. DOI: 10.1038/mp.2017.67. View

10.

Louveau A, Harris T, Kipnis J . Revisiting the Mechanisms of CNS Immune Privilege. Trends Immunol. 2015; 36(10):569-577. PMC: 4593064. DOI: 10.1016/j.it.2015.08.006. View

11.

Levy O . Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007; 7(5):379-90. DOI: 10.1038/nri2075. View

12.

Coughlin J, Wang Y, Ambinder E, Ward R, Minn I, Vranesic M . In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma. Transl Psychiatry. 2016; 6:e777. PMC: 4872398. DOI: 10.1038/tp.2016.40. View

13.

Meyer U, Feldon J . To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology. 2011; 62(3):1308-21. DOI: 10.1016/j.neuropharm.2011.01.009. View

14.

Paolicelli R, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P . Synaptic pruning by microglia is necessary for normal brain development. Science. 2011; 333(6048):1456-8. DOI: 10.1126/science.1202529. View

15.

Weinberger D . Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987; 44(7):660-9. DOI: 10.1001/archpsyc.1987.01800190080012. View

16.

Wray N, Wijmenga C, Sullivan P, Yang J, Visscher P . Common Disease Is More Complex Than Implied by the Core Gene Omnigenic Model. Cell. 2018; 173(7):1573-1580. DOI: 10.1016/j.cell.2018.05.051. View

17.

Kang H, Kawasawa Y, Cheng F, Zhu Y, Xu X, Li M . Spatio-temporal transcriptome of the human brain. Nature. 2011; 478(7370):483-9. PMC: 3566780. DOI: 10.1038/nature10523. View

18.

Veiga-Fernandes H, Pachnis V . Neuroimmune regulation during intestinal development and homeostasis. Nat Immunol. 2017; 18(2):116-122. DOI: 10.1038/ni.3634. View

19.

Radulescu E, Jaffe A, Straub R, Chen Q, Shin J, Hyde T . Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain. Mol Psychiatry. 2018; 25(4):791-804. DOI: 10.1038/s41380-018-0304-1. View

20.

Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R . Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci. 2014; 17(10):1418-1428. PMC: 4208299. DOI: 10.1038/nn.3801. View